Latest Covidien Plc. (COV) Headlines Covidien p
Post# of 48
Covidien plc to Report Second-Quarter Fiscal 2014 Results on April 25, 2014
Business Wire - Fri Mar 14, 6:00AM CDT
Covidien plc (NYSE: COV) will report second-quarter fiscal 2014 results on April 25. The company will host a conference call for investors at 8:30 a.m. ET. The call can be accessed in the following ways:
Hanger Downgraded to Strong Sell - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Mar 13, 3:41PM CDT
Hanger continues to face macroeconomic headwinds like reimbursement uncertainties, sequestration and RAC audits, which are likely to reduce the bottom line going forward.
Strength Seen in Chimerix (CMRX): Stock Soars 18.2% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Mar 13, 8:04AM CDT
Chimerix, Inc. was a big mover last session, as the company saw its shares rise over 18% on the day.
Q4 Loss Widens at Amedisys - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Mar 13, 8:00AM CDT
Amedisys recorded adjusted loss from continuing operations per share of 5 cents in the fourth quarter of 2013.
Covidien Launches Symbotex(TM) Composite Mesh for Surgical Laparoscopic and Open Ventral Hernia Repair
Business Wire - Thu Mar 13, 5:30AM CDT
Further strengthening its broad line of hernia repair products, Covidien plc (NYSE: COV) today announced the U.S. launch of Symbotex(TM) composite mesh, an innovative product designed to make it easier for surgeons to perform surgical laparoscopic and open ventral hernia repairs.
Updated Research Report on Abaxis - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Mar 12, 2:20PM CDT
On Mar 11, 2014, we issued an updated research report on Abaxis.
Midday Glance: Health Care Equipment companies
AP - Wed Mar 12, 12:28PM CDT
NEW YORK (AP) — Shares of some top health care equipment companies are mixed at 1 p.m.:
GW Pharmaceuticals (GWPH) Jumps: Stock Rises 6.6% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Mar 12, 8:18AM CDT
GW Pharmaceuticals plc (GWPH) was a big mover last session, as the company saw its shares rise by roughly 7% on the day.
Agios Pharmaceuticals (AGIO) in Focus: Stock Tumbles 8.1% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Mar 12, 7:48AM CDT
Agios Pharmaceuticals, Inc. (AGIO) saw a big move last session,reversing the recent trend for AGIO as the stock is now up around 37.7% in the past one-month time frame.
Coverage Initiated on ResMed - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Mar 11, 3:07PM CDT
On Mar 10, 2014, we initiated coverage on ResMed, Inc.
Wright Medical Group Reaches Agreement with ODE - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Mar 11, 2:20PM CDT
Last year, FDA issued a "not-approvable letter" in response to the PMA application submitted by Wright Medical Group for Augment Bone Graft.
Baxter International Recalls Peritoneal Dialysis Solution - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Mar 07, 2:00PM CST
Baxter distributed the product to dialysis centers, facilities, distributors, and patients in the U.S. between May 2013 and Jan 2014.
Early Glance: Health Care Equipment companies
AP - Fri Mar 07, 9:35AM CST
NEW YORK (AP) — Shares of some top health care equipment companies are down at 10 a.m.:
Covidien Next-Gen Ventilator Gets CE Mark - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Mar 06, 4:40PM CST
In a couple of trading days following the announcement, Covidien's stock rose 0.7% to close at $71.40 yesterday.
Perrigo Continues to Expand - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Mar 06, 11:50AM CST
Perrigo is constantly entering into acquisition and collaboration agreements to expand its business.
Sorrento Therapeutics (SRNE) Soars: Stock Up 8.6% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Mar 06, 8:39AM CST
Sorrento Therapeutics, Inc. was a big mover last session, as its shares rose nearly 9% on the day.
Covidien to Present at Barclays Global Healthcare Conference 2014
Business Wire - Thu Mar 06, 6:00AM CST
Covidien plc (NYSE: COV) will present at the Barclays Global Healthcare Conference 2014 in Miami on March 13. Charles J. Dockendorff, executive vice president and chief financial officer, will discuss the company in a presentation scheduled to begin at 10:45 a.m. ET.
Stryker Continues Acquisition Spree but Shares Fall - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Mar 05, 4:20PM CST
Since the announcement of both the acquisitions, shares of Stryker declined 1.8% till the last closing day.
Appointments, Earnings Results, Drug Applications, Conferences, and Approvals - Analyst Noteson Boston Scientific, Covidien, St. Jude Medical, Synageva BioPharma, and Ligand Pharmaceuticals
PR Newswire - Wed Mar 05, 3:00PM CST
Editor Note: For more information about this release, please scroll to bottom.